DNA DAY SPECIAL SALE! 65% Off + Free Shipping

Decoding the Mysteries of Hirschsprung Disease-Intellectual Disability Syndrome: A Guide to Understanding, Diagnosing, and Genetic Testing

Hirschsprung disease-intellectual disability syndrome, late infantile

Expert Reviewed By: Dr. Brandon Colby MD

Hirschsprung disease-intellectual disability syndrome, late infantile, is a rare genetic disorder that affects the nervous system and gastrointestinal function. This article aims to provide an in-depth understanding of the condition, its diagnosis, and the role of genetic testing in managing the disorder. By examining recent research and case studies, we will explore the unique clinical characteristics and genetic variants associated with the syndrome.

Understanding Hirschsprung Disease-Intellectual Disability Syndrome

This syndrome is characterized by a combination of Hirschsprung’s disease, a congenital disorder affecting the colon, and intellectual disability. Hirschsprung’s disease occurs due to the absence of nerve cells in certain parts of the colon, leading to severe constipation and intestinal obstruction. Intellectual disability, on the other hand, refers to limitations in intellectual functioning and adaptive behavior, affecting learning, communication, and social skills.

Recent research has uncovered rare genetic variants linked to the syndrome. In a case report titled Coffin-Siris Syndrome in a Patient with Hirschsprung’s Disease, a unique clinical characteristic and a rare genetic variant in ARID1B were identified in a male patient with both Coffin-Siris Syndrome and Hirschsprung’s disease.

Diagnosing the Syndrome

Diagnosing Hirschsprung disease-intellectual disability syndrome requires a thorough evaluation of the patient’s medical history, symptoms, and physical examination. The following diagnostic tests may be employed:

  • Rectal biopsy: To confirm the absence of nerve cells in the colon.
  • Barium enema: An X-ray examination of the colon using a contrast agent to detect abnormalities.
  • Genetic testing: To identify genetic mutations associated with the syndrome.

Genetic Testing: A Vital Tool in Diagnosis and Management

Genetic testing plays a crucial role in the diagnosis and management of Hirschsprung disease-intellectual disability syndrome. By identifying specific genetic mutations, healthcare providers can confirm the diagnosis, provide appropriate treatment, and offer genetic counseling to affected families.

Recent studies have highlighted the importance of genetic testing in the diagnosis of related conditions. A report on ARHGEF9 mutations causing a wide phenotypic spectrum found that mutations in the ARHGEF9 gene can lead to intellectual disability, behavior disorders, autism spectrum disorder, hyperekplexia, and infantile epileptic encephalopathy. Another case report on de novo 11q13.3q13.4 deletion in a patient with Fanconi renotubular syndrome and intellectual disability linked SHANK2 genes to intellectual disability and added a new phenotype to the deletion of this region.

Benefits of Genetic Testing in Hirschsprung Disease-Intellectual Disability Syndrome

Genetic testing offers several advantages in the management of Hirschsprung disease-intellectual disability syndrome:

  • Accurate diagnosis: Identifying specific genetic mutations can confirm the diagnosis and differentiate it from other conditions with similar symptoms.
  • Personalized treatment: Understanding the genetic basis of the syndrome can help healthcare providers tailor treatment plans to the individual needs of the patient.
  • Family planning: Genetic counseling can inform families about the risk of recurrence in future pregnancies and provide guidance on reproductive options.

Conclusion

Hirschsprung disease-intellectual disability syndrome is a complex genetic disorder that requires a comprehensive approach to diagnosis and management. Genetic testing plays a vital role in confirming the diagnosis, guiding treatment plans, and providing genetic counseling to affected families. By staying informed about the latest research and advancements in genetic testing, healthcare providers and families can work together to improve the lives of individuals with this rare syndrome.

About The Expert Reviewer

Dr. Brandon Colby MD is a US physician specializing in the personalized prevention of disease through the use of genomic technologies. He’s an expert in genetic testing, genetic analysis, and precision medicine. Dr. Colby is also the Founder of  and the author of ⁠⁠Outsmart Your Genes.

Dr. Colby holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University’s Graduate School of Business, and a degree in Genetics with Honors from the University of Michigan. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (⁠⁠ACMG), an Associate of the American College of Preventive Medicine (⁠⁠ACPM), and a member of the National Society of Genetic Counselors (⁠NSGC)

© 2025 Sequencing.com